126 related articles for article (PubMed ID: 23830236)
1. Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death.
Nurminen R; Lehtonen R; Auvinen A; Tammela TL; Wahlfors T; Schleutker J
Eur J Cancer; 2013 Oct; 49(15):3335-43. PubMed ID: 23830236
[TBL] [Abstract][Full Text] [Related]
2. Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.
Nurminen R; Rantapero T; Wong SC; Fischer D; Lehtonen R; Tammela TL; Nykter M; Visakorpi T; Wahlfors T; Schleutker J
Genes Chromosomes Cancer; 2016 Aug; 55(8):661-73. PubMed ID: 27113481
[TBL] [Abstract][Full Text] [Related]
3. Identification of an aggressive prostate cancer predisposing variant at 11q13.
Nurminen R; Wahlfors T; Tammela TL; Schleutker J
Int J Cancer; 2011 Aug; 129(3):599-606. PubMed ID: 21064104
[TBL] [Abstract][Full Text] [Related]
4. Germ-line alterations in MSR1 gene and prostate cancer risk.
Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
[TBL] [Abstract][Full Text] [Related]
5. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region.
Baffoe-Bonnie AB; Smith JR; Stephan DA; Schleutker J; Carpten JD; Kainu T; Gillanders EM; Matikainen M; Teslovich TM; Tammela T; Sood R; Balshem AM; Scarborough SD; Xu J; Isaacs WB; Trent JM; Kallioniemi OP; Bailey-Wilson JE
Hum Genet; 2005 Aug; 117(4):307-16. PubMed ID: 15906096
[TBL] [Abstract][Full Text] [Related]
6. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.
Rökman A; Ikonen T; Mononen N; Autio V; Matikainen MP; Koivisto PA; Tammela TL; Kallioniemi OP; Schleutker J
Cancer Res; 2001 Aug; 61(16):6038-41. PubMed ID: 11507049
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
[TBL] [Abstract][Full Text] [Related]
9. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
[TBL] [Abstract][Full Text] [Related]
10. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Nam RK; Zhang WW; Loblaw DA; Klotz LH; Trachtenberg J; Jewett MA; Stanimirovic A; Davies TO; Toi A; Venkateswaran V; Sugar L; Siminovitch KA; Narod SA
Prostate Cancer Prostatic Dis; 2008; 11(3):241-6. PubMed ID: 17876339
[TBL] [Abstract][Full Text] [Related]
12. Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer.
Camp NJ; Swensen J; Horne BD; Farnham JM; Thomas A; Cannon-Albright LA; Tavtigian SV
Genet Epidemiol; 2005 Apr; 28(3):232-43. PubMed ID: 15593091
[TBL] [Abstract][Full Text] [Related]
13. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
15. Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Nam RK; Zhang WW; Klotz LH; Trachtenberg J; Jewett MA; Sweet J; Toi A; Teahan S; Venkateswaran V; Sugar L; Loblaw A; Siminovitch K; Narod SA
Clin Cancer Res; 2006 Nov; 12(21):6452-8. PubMed ID: 17085659
[TBL] [Abstract][Full Text] [Related]
16. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Kote-Jarai Z; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Dadaev T; Jugurnauth-Little S; Ross-Adams H; Al Olama AA; Benlloch S; Halim S; Russell R; Dunning AM; Luccarini C; Dennis J; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubinski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle A; Clements JA; Teixeira MR; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dicks E; Baynes C; Conroy D; Bojesen SE; Kaaks R; Vincent D; Bacot F; Tessier DC; ; ; ; ; Easton DF; Eeles RA
Hum Mol Genet; 2013 Jun; 22(12):2520-8. PubMed ID: 23535824
[TBL] [Abstract][Full Text] [Related]
17. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer.
Wang L; McDonnell SK; Slusser JP; Hebbring SJ; Cunningham JM; Jacobsen SJ; Cerhan JR; Blute ML; Schaid DJ; Thibodeau SN
Cancer Res; 2007 Apr; 67(7):2944-50. PubMed ID: 17409399
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.
Tindall EA; Severi G; Hoang HN; Ma CS; Fernandez P; Southey MC; English DR; Hopper JL; Heyns CF; Tangye SG; Giles GG; Hayes VM;
Carcinogenesis; 2010 Oct; 31(10):1748-54. PubMed ID: 20403914
[TBL] [Abstract][Full Text] [Related]
19. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
20. Influence of MUC1 genetic variation on prostate cancer risk and survival.
Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
